TCM
PGEN icon

Traynor Capital Management’s Precigen PGEN Stock Holding History

Traynor Capital Management’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-22,016
Closed -$739K – 132
2016
Q1 		$739K Sell
22,016
-16,415
-43% -$517K 0.59% 38
2015
Q4 		$1.15M Buy
38,431
+8,486
+28% +$286K 0.83% 29
2015
Q3 		$943K Buy
29,945
+8,781
+41% +$428K 0.81% 27
2015
Q2 		$1.02M Buy
21,164
+5,762
+37% +$243K 0.85% 25
2015
Q1 		$667K Buy
+15,402
New +$553K 0.64% 31

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Traynor Capital Management's PGEN Position: Q2 2016 in Review

Traynor Capital Management sold out of Precigen (PGEN) in Q2 2016, closing a stake of 22,016 shares — an estimated $739K sold.

Traynor Capital Management first reported a position in PGEN in Q1 2015 and held it in 5 quarters. The position peaked at $1.15M in Q4 2015. 169 funds tracked by Wall St. Rank hold PGEN as of Q2 2016.

  • Traynor Capital Management reported no remaining Precigen position as of Q2 2016 after selling out during the quarter.
  • Traynor Capital Management sold 22,016 Precigen shares in Q2 2016, an estimated $739K.
  • Traynor Capital Management first reported a position in Precigen in Q1 2015 and held it in 5 quarters.
  • Traynor Capital Management's Precigen position peaked at $1.15M in Q4 2015.
  • 169 funds tracked by Wall St. Rank held Precigen as of Q2 2016.

Based on Traynor Capital Management's 13F filing for Q2 2016, filed 27 Jul 2016.